ERBB2 and breast cancer: Furthermore, NAC therapy is sometimes indicated in early ER-positive BC in order to downstage the tumor; however, it is well known that patients with ER-positive BC are not likely to achieve a pathologic complete response (pCR), contrary to patients with TNBC and HER2-positive disease.